Immunogenicity and Safety of Imovax Polio in Chinese Infants Compared to Local OPV

NCT00348387 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
600
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi Pasteur, a Sanofi Company